COUNTERPOINT: Men should be treated for hormone refractory prostate cancer with systemic chemotherapy when they are symptomatic, and not before
Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Dec
2003 (Vol.
10, Issue
6, Pages(
2038 - 2039)